Search Results - "Hegge, Karly A."

Metronidazole-Induced encephalopathy: a Case Report and Review of the Literature by Bottenberg, Michelle M., Hegge, Karly A., Eastman, Darla Klug, Kumar, Ravinder

Get full text

Sapropterin: A New Therapeutic Agent for Phenylketonuria by Hegge, Karly A, Horning, Kristin K, Peitz, Gregory J, Hegge, Kassy

“…Objective: To summarize the role of pharmacotherapy in the management of phenylketonuria (PKU) and to review the pharmacology, pharmacokinetics,…”
Get full text

Adherence to treatment guidelines in two primary care populations with gout by Wall, Geoffrey C., Koenigsfeld, Carrie F., Hegge, Karly A., Bottenberg, Michelle M.

“…Published guidelines for the treatment of gout aim to improve the evidenced-based management of this disorder. Unfortunately, several studies suggest that…”
Get full text

Denosumab: A Novel Agent for Osteoporosis by Horning, Kristin K, Hegge, Karly A, Bottenberg, Michelle M

“…Objective: To review the pharmacology, pharmacokinetics, clinical efficacy, and safety of denosumab, a biologic antiresorptive agent for treatment of…”
Get full text

New Therapies for Osteoporosis by Hegge, Karly A., Fornoff, Anisa S., Gutierres, Sheryl L., Haack, Sally L.

“…Osteoporosis is a growing health concern in the United States, with an enormous impact on morbidity and mortality. Despite published guidelines to aid…”
Get full text

Antiplatelet agents for prevention of recurrent ischemic stroke by Hegge, Karly A

“…Prevention of secondary stroke is an important objective in the management of patients with ischemic stroke or TIA. Commonly used antiplatelet regimens for…”
Get more information

Intensive insulin therapy in critical care settings by Eastman, Darla Klug, Bottenberg, Michelle M, Hegge, Karly A, Ourth, Heather, Kabadi, Udaya

“…Hyperglycemia in hospitalized patients has been shown to increase both morbidity and mortality, regardless of the presence of preexisting diabetes. In order to…”
Get more information